TrialJournal of clinical immunology2011

Efficacy and safety of subcutaneous vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter study.

Michael Borte et al.PubMed ↗Publisher ↗

No numbers read from the abstract.